Watch our podcast from the recent European Society of Cardiology (ESC) Congress, which highlights some of the key studies presented there with an interpretation by experts who give us their practice messages.
For advances in atrial fibrillation, we talk to Professor John Camm (St George’s, University of London), who analyses new AF guidance and the registry ‘real world’ data emerging in this field.
Dr Jubin Joseph (St Thomas’ Hospital, London, and President of the British Junior Cardiologists’ Association) speaks about the implications of some of the coronary artery disease studies, and also the use of telemonitoring in heart failure.
Finally, Professor Patrick Moriarty (University of Kansas Medical Center, Kansas City, USA) discusses what effect the new PCSK9 inhibitors are likely to have on life for patients with familial hypercholestorolaemia.
For ease of viewing, the podcast is divided into four installments. Visit www.bjcardio.co.uk/podcasts now!
